• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自较少探索生态系统的放线菌对结核分枝杆菌和其他非结核分枝杆菌病原体的生物活性潜力

Bioactive Potential of Actinomycetes from Less Explored Ecosystems against Mycobacterium tuberculosis and Other Nonmycobacterial Pathogens.

作者信息

Manikkam Radhakrishnan, Venugopal Gopikrishnan, Subramaniam Balaji, Ramasamy Balagurunathan, Kumar Vanaja

机构信息

Centre for Drug Discovery and Development, Sathyabama University, Chennai, Tamil Nadu 600 119, India.

Department of Microbiology, Periyar University, Salem, Tamil Nadu 636 011, India.

出版信息

Int Sch Res Notices. 2014 Nov 9;2014:812974. doi: 10.1155/2014/812974. eCollection 2014.

DOI:10.1155/2014/812974
PMID:27437460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4897172/
Abstract

Bioactive potential of actinomycetes isolated from certain less explored Indian ecosystems against Mycobacterium tuberculosis and other nonmycobacterial pathogens was investigated. Actinomycetes were isolated from the soil samples collected from desert, coffee plantation, rubber forest, and hill area and their cultural and micromorphological characteristics were studied. Crude extracts were prepared by agar surface fermentation and tested against M. tuberculosis isolates by luciferase reporter phage (LRP) assay at 100 µg/mL. Activity against nonmycobacterial pathogens was studied by agar plug method. Totally 54 purified cultures of actinomycetes including 43 Streptomyces and 11 non-Streptomyces were isolated. While screening for antitubercular activity, extracts of 39 actinomycetes showed activity against one or more M. tuberculosis isolates whereas 27 isolates exhibited antagonistic activity against nonmycobacterial pathogens. In particular crude extracts from sixteen actinomycete isolates inhibited all the three M. tuberculosis isolates tested. Findings of the present study concluded that less explored ecosystems investigated in this study are the potential resource for bioactive actinomycetes. Further purification and characterization of active molecule from the potential extracts will pave the way for determination of MIC, toxicity, and specificity studies.

摘要

对从印度某些较少被探索的生态系统中分离出的放线菌针对结核分枝杆菌和其他非结核分枝杆菌病原体的生物活性潜力进行了研究。从沙漠、咖啡种植园、橡胶林和山区采集的土壤样本中分离出放线菌,并研究了它们的培养和微观形态特征。通过琼脂表面发酵制备粗提物,并以100µg/mL的浓度通过荧光素酶报告噬菌体(LRP)测定法对结核分枝杆菌分离株进行测试。通过琼脂块法研究对非结核分枝杆菌病原体的活性。总共分离出54株纯化的放线菌培养物,包括43株链霉菌和11株非链霉菌。在筛选抗结核活性时,39株放线菌的提取物对一种或多种结核分枝杆菌分离株表现出活性,而27株分离株对非结核分枝杆菌病原体表现出拮抗活性。特别是,来自16株放线菌分离株的粗提物抑制了所有测试的三种结核分枝杆菌分离株。本研究结果得出结论,本研究中调查的较少被探索的生态系统是生物活性放线菌的潜在资源。从潜在提取物中进一步纯化和表征活性分子将为确定最低抑菌浓度、毒性和特异性研究铺平道路。

相似文献

1
Bioactive Potential of Actinomycetes from Less Explored Ecosystems against Mycobacterium tuberculosis and Other Nonmycobacterial Pathogens.来自较少探索生态系统的放线菌对结核分枝杆菌和其他非结核分枝杆菌病原体的生物活性潜力
Int Sch Res Notices. 2014 Nov 9;2014:812974. doi: 10.1155/2014/812974. eCollection 2014.
2
Antibacterial activity of actinomycetes isolated from different soil samples of Sheopur (A city of central India).从印度中部城市绍布尔不同土壤样本中分离出的放线菌的抗菌活性。
J Adv Pharm Technol Res. 2013 Apr;4(2):118-23. doi: 10.4103/2231-4040.111528.
3
Antagonistic Potential of Soil Isolates from Southern Thailand to Inhibit Foodborne Bacterial Pathogens.泰国南部土壤分离物对食源性病原体的拮抗潜力
Int J Microbiol. 2021 Aug 30;2021:2545441. doi: 10.1155/2021/2545441. eCollection 2021.
4
Generation of a high quality library of bioactive filamentous actinomycetes from extreme biomes using a culture-based bioprospecting strategy.采用基于培养的生物勘探策略,从极端生物群落中生成高质量的生物活性丝状放线菌文库。
Front Microbiol. 2023 Jan 19;13:1054384. doi: 10.3389/fmicb.2022.1054384. eCollection 2022.
5
Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas, India.对从印度克什米尔喜马拉雅山脉未开发地区分离出的特定土壤放线菌进行的抗菌研究。
Microb Pathog. 2017 Sep;110:93-99. doi: 10.1016/j.micpath.2017.06.017. Epub 2017 Jun 22.
6
Antimicrobial and enzymatic activity of actinomycetes isolated from soils of coastal islands.从沿海岛屿土壤中分离出的放线菌的抗菌和酶活性
J Adv Pharm Technol Res. 2017 Apr-Jun;8(2):46-51. doi: 10.4103/japtr.JAPTR_161_16.
7
Antimicrobial Potential of spp. Isolated from the Rift Valley Regions of Ethiopia.从埃塞俄比亚裂谷地区分离出的[具体物种]的抗菌潜力。 (注:原文中“ spp.”部分信息缺失,这里按格式保留了原文的样子)
Adv Pharmacol Pharm Sci. 2022 Jun 13;2022:1724906. doi: 10.1155/2022/1724906. eCollection 2022.
8
Terrestrial actinomycetes from diverse locations of Uttarakhnad, India: Isolation and screening for their antibacterial activity.来自印度北阿坎德邦不同地点的陆生放线菌:分离及其抗菌活性筛选。
Iran J Microbiol. 2013 Sep;5(3):299-308.
9
[Study of marine actinomycetes isolated from the central coast of Peru and their antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis].[从秘鲁中部海岸分离的海洋放线菌及其对耐甲氧西林金黄色葡萄球菌和耐万古霉素粪肠球菌的抗菌活性研究]
Rev Peru Med Exp Salud Publica. 2011 Jun;28(2):237-46.
10
Isolation of Actinomycetes with Cellulolytic and Antimicrobial Activities from Soils Collected from an Urban Green Space in the Philippines.从菲律宾城市绿地采集的土壤中分离具有纤维素分解和抗菌活性的放线菌。
Int J Microbiol. 2021 Mar 17;2021:6699430. doi: 10.1155/2021/6699430. eCollection 2021.

引用本文的文献

1
Actinomycetes from high altitude salt lake Tso-Kar of Ladakh offers bright prospects for antimycobacterial drug discovery especially for drug resistant mycobacteria.来自拉达克高海拔盐湖措果的放线菌为抗分枝杆菌药物的发现带来了光明前景,尤其是针对耐药分枝杆菌。
Extremophiles. 2025 Aug 1;29(2):33. doi: 10.1007/s00792-025-01398-y.
2
Bioactive metabolites of display broad-spectrum antimicrobial activity against multidrug-resistant bacteria and fungi.显示出的生物活性代谢产物对多种耐药菌和真菌具有广谱抗菌活性。
Front Cell Infect Microbiol. 2023 Apr 24;13:1162721. doi: 10.3389/fcimb.2023.1162721. eCollection 2023.
3
Taxonomy and Broad-Spectrum Antifungal Activity of sp. SCA3-4 Isolated From Rhizosphere Soil of .从[具体植物名称]根际土壤中分离出的SCA3-4菌株的分类学及广谱抗真菌活性
Front Microbiol. 2019 Jun 28;10:1390. doi: 10.3389/fmicb.2019.01390. eCollection 2019.
4
Antimicrobial potentiality of actinobacteria isolated from two microbiologically unexplored forest ecosystems of Northeast India.从印度东北部两个微生物尚未开发的森林生态系统中分离出的放线菌的抗菌潜力。
BMC Microbiol. 2018 Jul 11;18(1):71. doi: 10.1186/s12866-018-1215-7.
5
Terpenoid bioactive compound from Streptomyces rochei (M32): taxonomy, fermentation and biological activities.来自罗氏链霉菌(M32)的萜类生物活性化合物:分类学、发酵及生物活性
World J Microbiol Biotechnol. 2016 Oct;32(10):161. doi: 10.1007/s11274-016-2121-5. Epub 2016 Aug 25.
6
Broad Spectrum Antimicrobial Activity of Forest-Derived Soil Actinomycete, Nocardia sp. PB-52.森林来源的土壤放线菌诺卡氏菌属PB-52的广谱抗菌活性
Front Microbiol. 2016 Mar 18;7:347. doi: 10.3389/fmicb.2016.00347. eCollection 2016.

本文引用的文献

1
Unexplored hypersaline habitats are sources of novel actinomycetes.未被探索的高盐生境是新型放线菌的来源。
Front Microbiol. 2014 May 27;5:242. doi: 10.3389/fmicb.2014.00242. eCollection 2014.
2
Antimycobacterial susceptibility testing methods for natural products research.天然产物研究中的抗分枝杆菌药敏试验方法。
Braz J Microbiol. 2010 Apr;41(2):270-7. doi: 10.1590/S1517-83822010000200001. Epub 2010 Jun 1.
3
Antibiotics in the clinical pipeline in 2013.2013 年临床研发中的抗生素。
J Antibiot (Tokyo). 2013 Oct;66(10):571-91. doi: 10.1038/ja.2013.86. Epub 2013 Sep 4.
4
Abyssomicins from the South China Sea deep-sea sediment Verrucosispora sp.: natural thioether Michael addition adducts as antitubercular prodrugs.来自中国南海深海沉积物疣孢菌属的深渊霉素:作为抗结核前药的天然硫醚迈克尔加成加合物。
Angew Chem Int Ed Engl. 2013 Jan 21;52(4):1231-4. doi: 10.1002/anie.201208801. Epub 2012 Dec 6.
5
Thoughts and facts about antibiotics: where we are now and where we are heading.关于抗生素的思考与事实:我们现在所处的位置和未来的走向。
J Antibiot (Tokyo). 2012 Aug;65(8):385-95. doi: 10.1038/ja.2012.27. Epub 2012 Apr 18.
6
Atacamycins A-C, 22-membered antitumor macrolactones produced by Streptomyces sp. C38.阿塔克霉素 A-C,由链霉菌 C38 产生的具有 22 个成员的抗肿瘤大环内酯。
J Antibiot (Tokyo). 2011 Dec;64(12):775-80. doi: 10.1038/ja.2011.96. Epub 2011 Oct 19.
7
Drugs in development for tuberculosis.正在研发中的结核病药物。
Drugs. 2010 Dec 3;70(17):2201-14. doi: 10.2165/11538170-000000000-00000.
8
Bioprospecting for antituberculosis leads from microbial metabolites.从微生物代谢产物中寻找抗结核先导化合物。
Nat Prod Rep. 2010 Nov;27(11):1709-19. doi: 10.1039/c0np00008f. Epub 2010 Oct 4.
9
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004.1998 - 2004年美国急性中耳炎患儿广谱抗生素处方趋势
BMC Pediatr. 2009 Jun 24;9:41. doi: 10.1186/1471-2431-9-41.
10
Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.新型4-(吗啉-4-基)-N'-(亚芳基)苯甲酰肼:合成、抗分枝杆菌活性及定量构效关系研究
Eur J Med Chem. 2009 Oct;44(10):3954-60. doi: 10.1016/j.ejmech.2009.04.023. Epub 2009 Apr 22.